Jeffrey Holford

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Jeffrey Holford is focused on the Healthcare sector with 450 price targets and ratings documented since 2012 spanning on 9 stocks. Previously, Jeffrey Holford worked at JEFFERIES. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 864 days.

Most recent stock forecast was given on MRK, Merck & Co., Inc at 14-Feb-2018.

Jeffrey Holford best performing recommendations are on ABBV (ABBVIE INC).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) at 10/13/2014. The price target of $50 was fulfilled within 92 days with a profit of $11.34 (29.33%) receiving and performance score of 3.19.

Average potential price target upside

of $35.63 (79.99%) on ABBV (ABBVIE INC).
of $25.01 (31.14%) on JNJ (JOHNSON & JOHNSON).
of $22.98 (34.95%) on LLY (ELI LILLY AND COMPANY).

Currently, out of the existing stock ratings of Jeffrey Holford - 17366 which are a Buy (57.42%), 11661 which are a Hold (38.55%), 1219 which are a Sell (4.03%)